Using non-invasive in vivo imaging and experimental autoimmune uveoretinitis as a model we show for the first time, that the mechanisms controlling blood monocyte recirculation through peripheral and lymphoid tissues alter during inflammation. The recirculation of monocytes in mice with ocular inflammation, but not controls was found to be dependent upon CD62-L and CD44. Not only was rolling efficiency ablated or markedly reduced in antibody treated mice, the majority of labelled monocytes disappeared from the circulation within seconds, anti-CD44 treated monocytes homing to the lymph nodes and anti-CD62-L treated monocytes homing to the spleen. Our data indicate that while PSGL-1 has a partial role in the transmigration of monocytes into the inflamed retina, CD62-L has a key role in regulating recruitment of monocytes to lymphoid tissue from the blood during inflammation and that CD44 is required to maintain CD62-L +ve inflammatory monocytes within the circulation during inflammation. This effect was systemic, as sequestered monocytes accumulated in mesenteric as well as draining cervical lymph nodes, and inflammation dependent, as depletion of circulating blood monocytes was much reduced or absent in normal mice and accumulations of adoptively transferred monocytes in the lymphoid tissues did not occur.
INTRODUCTION
Non-differentiated monocytes are known to circulate in the blood and tissues for up to three days, and during that time they are recruited to the tissues where they differentiate into macrophages or myeloid dendritic cells [1] [2] [3] . Subsets of blood monocytes with differential migratory potential have been identified, and the capacity of monocytes to preferentially migrate to sites of inflammation has been linked to expression of the selectin CD62-ligand (CD62L), CC-chemokine receptor-2 (CCR-2) and CD14, whilst subsets that are CCR-2 -ve and CD16 +ve are recruited to tissues independently of inflammatory stimuli to become resident monocyte macrophages or myeloid DC 4 . More recently,
we have shown that differentiation and recruitment of the inflammatory subset is independent of local inflammatory stimuli, requiring monocyte conditioning or differentiation over time within the circulation. Bone marrow derived monocytes (BM-Mo) transferred i.v. to mice with established ocular inflammation, required 24-48h in vivo conditioning before being able to roll on endothelium efficiently and migrate into the inflamed retina. This capacity to roll and migrate was largely lost after 72h in the circulation. In the retina, adoptively transferred, in vivo conditioned monocytes differentiated into CD11c +ve, B220 +ve DC, and F4/80 +ve macrophages, indicating that a permissive endothelium alone, is not sufficient for active recruitment of monocytes from the blood 3 .
Understanding the processes involved in mononuclear myeloid cell trafficking has considerable importance both for the targeting of antigen pulsed DC used as vaccines and for the control of inflammatory diseases 5, 6 . Recruitment of mononuclear myeloid cells from the blood to the tissue and from the tissue to lymph nodes is controlled by adhesive interactions between the cell and the vascular or lymphatic endothelium. The mechanisms involved in recruitment of leukocyte subsets from the blood to the tissues and lymphoid organs have been extensively studied, primarily in in vitro model systems under defined molecular conditions. Multiple molecules, constitutively expressed or induced under inflammatory conditions, have been identified as playing a role in monocyte adhesion and diapedesis 7, 8 . The multi-step paradigm that has emerged invokes weak interactions via selectins that allow leukocyte rolling on vascular endothelium that initiates an
For personal use only. on April 30, 2017 . by guest www.bloodjournal.org From adhesion cascade. This is triggered by chemokines and results in firm adhesion and spreading of the monocyte on the endothelium through regulation of avidity of β 1 -integrins and β 2 -integrins 9, 10 . Fast rolling is mediated by CD62-L 11 and is regulated by vessel wall shear stress 12 . Rolling through Eor P-selectin is slower, but is also shear stress dependent when rolling on P-selectin glycoprotein ligand-1 (PSGL-1) 13 . This dependence on shear stress is believed to limit leukocyte interactions in the centre of vessels or in vessels with very high or very low wall shear stress, and the steady rolling generated enables the leukocyte to receive crucial activating stimuli from the endothelium. Some
overlapping and redundancy appears to exist in the system 14 , and mechanisms controlling monocyte trafficking to a Th1-type inflammatory lesion under physiological conditions of flow in vivo are not known.
Using experimental autoimmune uveoretinitis (EAU) as a model inflammation, we have been able to demonstrate mechanisms controlling specific T lymphocyte subset rolling, sticking and trans-endothelial cell migration within normal and diseased neurovascular post-capillary endothelial venules where shear stress levels are relatively high [15] [16] [17] . A reduction in shear stress in retinal veins from about 30 dyn/cm 2 to 20 dyn/cm occurs up to 24h prior to leukocyte infiltration, and rolling and sticking efficiencies are negatively correlated with wall shear stress, providing a good model for studying leukocyte subset trafficking in vivo during inflammation . In this study we focus on the kinetics of monocyte trafficking in vivo, and in particular on the role of CD44 which is implicated in primary adhesive interactions between leukocytes and endothelium 18 and has a major role in leukocyte homing in EAU 19 , as well as CD-62L and PSGL-1 which have been shown to account for at least 90% of leukocyte rolling in vivo 20 . In addition to mediating monocyte infiltration of the inflammatory site, we show for the first time, that CD62-L has a key role in regulating recruitment of monocytes to lymphoid tissue from the blood during inflammation and that CD44 is also required to maintain CD62-L +ve inflammatory monocytes within the circulation during inflammation. Unexpectedly, this effect was systemic as distant as well as draining lymph nodes
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MATERIALS AND METHODS
Animals and retinal inflammation model. Eight-12 week old wild type C57BL/6 mice and homozygous C57BL/6 mice expressing EGFP under the control of a chicken β-actin promoter and cytomegalovirus enhancer were maintained in the Medical Research Facility at Aberdeen University. Experimental autoimmune uveoretinitis (EAU) was induced in wild type C57BL/6 mice as described 21 . Retinal inflammation occurred at day 16-18 pi and peaked at day 21-28 pi. All procedures were approved by Home Office Regulations for Animal Experimentation, UK.
In vivo monocyte trafficking using scanning laser ophthalmolscopy (SLO).
Lymphocyte depleted bone marrow monocyte (BM-Mo) were prepared from EGFP + bone marrow cells as described 3 . In vivo monocyte trafficking was studied using our SLO technique as described 22, 23 . This non-surgical technique minimises any leukocyte trafficking artifacts. The retinal vasculature is imaged through the intact cornea, and adoptively transferred leukocytes may be tracked as they enter via the retinal artery, traverse the capillary network and exit via the retinal vein. Mice are unharmed by the procedure, and can be re-scanned over several days if necessary.
Briefly, mice were anaesthetized with an intramuscular injection of 0.4 ml/kg Hypnorm (JanssenCilag Ltd. Video analysis was carried out off-line as described 17, 24 . This protocol excludes any neutrophils present in the EGFP + BM-Mo transfers as neutrophils released from the bone marrow die rapidly 
RESULTS
In vivo kinetics of monocyte recirculation through the inflamed EAU retina and effect of blocking mAb to CD62-L, PSGL-1, CD44 and LFA-1. Figure 1 shows the kinetics of monocyte recirculation measured by SLO imaging of inflamed eyes.
Data was recorded from mice with EAU 48h post monocyte transfer and the effects of mAb treatment on recirculation, rolling efficiency and sticking efficiency was measured. Analysis of SLO images showed that the normal rate of EGFP + monocyte re-circulation through inflamed vessels was 11.9 ± 5.6 cells per min. The rolling efficiency of these monocytes on the endothelium varied considerably, depending on the extent of inflammation (as assessed by vessel leakage of low concentration fluorecein dye co-injected with cells), but the average rolling efficiency (i.e. % of
For personal use only. on April 30, 2017 . by guest www.bloodjournal.org From transferred cells passing through vessel that rolled on endothelium) was 37.8 ± 15.7, similar to our previous observations in this model 3 . The average sticking efficiency of monocytes adhering to endothelium was 8.7 ± 6.6. LFA-1 is essential for T cell trafficking but has been shown not to be involved in monocyte adhesion and diapedesis in vitro 8 we therefore included CD11a blocking mAb M17/4 as an additional irrelevant mAb control group for these studies.
After baseline measurements had been recorded, the role of specific adhesion molecules was tested by infusing blocking mAb i. CD62-P (P-selection) is upregulated on retinal venules, the principal sites of leukocyte adhesion and diapedesis in EAU, at the time of BRB breakdown and leukocyte infiltration of the retina 16 . We therefore also examined the effect of blocking PSGL-1, a ligand for both P-and Eselectin, which has been shown to mediate monocyte/platelet aggregations, secondary tethering and integrin activation (Figure 1 ) 30 . Treatment with PSGL-1 mAb had no significant effect on circulating EGFP + cell numbers, but rolling efficiency was significantly reduced (p<0.05). In this group PSGL-1 mAb also had an overall significant effect on sticking efficiency (p<0.05), but this was an "all or none" effect. This could reflect a threshold effect indicating that in some mice PSGL-1-independent molecular receptors were involved, possibly linked to haemodynamic
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In groups where mAb treatment did not deplete circulating EGFP + monocytes, rolling velocity was measured on inflamed endothelium (Fig. 2) 
Circulating monocyte depletion by CD62-L mAb MEL-14 and CD44 mAb IM7 is inflammation dependent
Inflammatory processes impose activating phenotypes on both endothelium and leukocyte, so to identify antibody-dependent clearance mechanisms as a reason for the sudden loss of circulating EGFP + monocytes after treatment with MEL-14 and IM7 mAbs, we examined the effect of these antibodies on the recirculation of monocytes through the retina in normal mice in comparison to EAU mice. Figure 3A&B shows that adoptively transferred EGFP monocytes re-circulated through the normal retina at approximately the same rate (25.7 ± 2.7 cells/min) as in inflamed EAU retinas (Fig.1 ). This value was not reduced after infusion of CD62-L mAb (24.8 ± 2.23 cells/min), however, in CD44 mAb treated normal mice a significant reduction in re-circulating monocytes was observed 2-5 min after infusion (from 24.2 ± 2 to 16.4 ± 2.1 cells/min; p<0.05). Infusion of mAb can temporarily sequester target cells within tissues such as the lung, and when SLO measurements of re-circulating cells were recorded over time, a sudden dip in EGFP monocytes passing through the retina was seen in both controls and EAU mice 2m after mAb infusion (Fig. 3, C&D) . This was a temporary effect in normal mice, as the rate of recirculating EGFP monocytes increased back to control levels after 12 minutes. In EAU mice the numbers of re-circulating monocytes in both CD62-L and CD44 mAb treated EAU mice continued to fall, and remained profoundly reduced compared to control (p<0.01 in both groups), showing that the depletion of circulating monocytes observed in EAU mice was inflammation specific.
Differential trafficking of monocytes to lymphoid tissues in EAU, but not control mice treated with CD62-L mAb MEL-14 or CD44 mAb IM7 .
To determine the fate of adoptively transferred monocytes, organs and tissues of groups of recipient EAU and normal control mice, were examined using flow cytometry and microscopy 30m and 24h after a single infusion of mAb, and at 72h after 3 infusions of mAb. Figure 4A -C shows that 30m post-infusion with MEL-14 anti-CD62L antibody, adoptively transferred monocytes were found dispersed throughout the venous sinuses of the spleen, but were restricted to the subcapsular sinuses of lymph nodes, whereas in IM7 anti-CD44 antibody treated mice, monocytes had entered the node and were present within the medullary sinus and in clusters around vessels. In the spleen, eGFP +ve monocytes were also found throughout the venous sinuses and red pulp, and notably in large numbers clustered around and in the marginal zones of the lymphoid follicles (Fig 4C) . This rapid accumulation of transferred monocytes within the lymphoid tissues, particularly in IM7 treated mice provides an explanation for the sudden loss of circulating fluorescent cells in the retina observed by SLO (Figs 1 and 3) . After 24h these relatively large accumulations of eGFP expressing cells were no longer evident, only a few scattered cells being detectable using the APAAP Using more sensitive detection technique of confocal microscopy to follow fate of eGFP +ve cells in the tissues we were able to show significant accumulations of adoptively transferred monocytes in lymphoid tissues of mice with EAU after 3 days treatment with CD62-L or CD44 mAb compared with control IgG, LFA-1 or PSGL-1 mAbs (Fig 4 D,E and Fig 5) . Sectioning of lymph nodes, spleen, and other tissues revealed that in EAU mice treated with CD62-L mAb, Monocytes as well as retinal antigen specific T cells are required for full expression of EAU, and mechanisms for monocyte migration into peripheral inflamed tissues rather than lymphoid tissues are likely to differ 14 . We therefore examined the effect of blocking mAb on the migration of adoptively transferred monocytes into inflamed retina. Mice with EAU were treated with 30µg
Ig/mouse/day for three days after infusion of donor EGFP + monocytes. After 72h, blood samples were taken for FACS analysis, the mice killed and retinal whole mounts prepared for confocal microscopy. Figure 6A shows that 72h after injection, small numbers of transferred EGFP + cells continued to circulate despite significant sequestration of cells in the lymphoid tissues of EAU mice treated with CD62-L or CD44 mAbs. EGFP + monocyte numbers in the blood of CD62-L and CD44 mAb treated mice were depleted compared to control Ig treated mice, but this was significant only for the CD44 mAb treated group (p<0.01). Treatment with CD62-L, CD44 and PSGL-1 mAbs to also significantly reduced the numbers of infiltrating EGFP + monocytes in the retinas of EAU mice compared to isotype and LFA-1 mAb treated control groups (p<0.01), confirming that CD11a also has no role in inflammatory monocyte trafficking in vivo (Fig. 6B) . (Fig. 6C) and normal control mice (Fig. 6D) after 3 days mAb treatment. CD44 expression (Geo-MFI) was very much lower on monocytes from all groups of EAU mice compared with normal mouse groups suggesting that monocyte transmembrane CD44 was lost during inflammation.
Treatment with the mAbs had relatively minor effects on surface expression of adhesion molecules examined. Statistical analysis showed some significant differences. Treatment with CD62-L mAb reduced CD44 expression and treatment with PSGL-1 mAb increased LFA-1 expression on monocytes from EAU but not control mice. However, whether these changes were sufficient to exert physiological effects is in doubt as Geo-MFI changes did not mirror in vivo functional changes observed in earlier experiments.
DISCUSSION
Differential trafficking is known to be required for localisation of effector leukocyte subsets, either to sites of inflammation or to lymphoid tissues, and tissue specific chemokine expression and receptor signalling has been identified as providing specificity to endothelial traffic signals, raising the concept of molecular codes specific for particular disease processes. 5 Previously we have shown that a permissive endothelium alone is not sufficient to recruit monocytes from the circulation 3 , but data we present here supports the concept of differential monocyte trafficking in vivo in steady state and inflammation, with specific roles identified for CD62-L and CD44 in maintaining monocytes within the circulation during inflammation. Blockade of CD62-L caused retention of monocytes within the spleen whilst blockade of CD44 caused retention of monocytes within the lymph nodes. Surprisingly, this effect was inflammation specific as blockade of CD62-L and CD44 had no apparent effect on the ability of monocytes to recirculate in normal mice. These observations are also consistent with a role for CD62-L and CD44 in directing circulating monocytes to other non-lymphoid tissues such as bone marrow in the absence of inflammation 34 .
Identifying signals controlling monocyte differentiation and function in inflammation versus steady
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For monocytes, two major subsets have been identified with differing chemokine and adhesion molecule expression that govern trafficking potential to inflammatory sites 6 . Recently we showed that acquisition of the inflammatory monocyte phenotype is a time limited property of monocytes independent of external inflammatory signals. Bone marrow derived monocytes adoptively transferred into normal mice re-circulated freely for at least 72h and viable monocytes could be found in both lymph nodes and spleen throughout the sampling period 3 . When injected into mice with EAU, adoptively transferred monocytes did not migrate into the inflamed retinal tissue until 24-48h after transfer, despite repeated trafficking through inflamed retinal vessels. This time frame coincided with acquisition of maximum rolling efficiency and maximal expression of CCR2 and LFA-1 by monocytes. These data indicate that an inflamed endothelium and associated chemokine and cytokine microenvironment is not sufficient to recruit circulating monocytes, and new monocytes leaving the bone marrow require in vivo conditioning over a defined time period before switching to a phenotype that enables homing to inflammatory sites. In the experiments described here we have included a 48h in vivo conditioning period to allow inflammatory monocyte maturation/differentiation before taking SLO measurements or administering mAb treatments to examine mechanisms controlling monocyte recirculation and homing to an inflammatory site in
vivo.
The main physiological function of selectins is to allow high affinity rolling interactions between leukocytes and the endothelium under flow, mediating signal transduction and firm adhesion 20, 35 . For these experiments we examined the role of CD62-L as it is expressed by most monocytes and has been implicated in mediating inflammatory monocyte migration 6 . PSGL-1 was also chosen as the interaction between P/E selectin and PSGL-1 induces changes in integrin function and increased adhesion of monocytes to endothelium in vitro 30 , but to date there is no record of its role in mediating monocyte function in DTH inflammation in vivo. CD44 was also included in this study as both CD44 and its ligand hyaluronan are upregulated in the EAU eye 16 , and although implicated in lymphocyte function in both in the uveitic eye and other DTH models, no specific role for CD44 in monocyte trafficking has been identified. Antibodies to CD11a were included to confirm that LFA-1 has no role in monocyte adhesion and diapedesis in vivo in our model, and provided a useful additional negative control for our assays. VLA-4 has been implicated in monocyte trafficking in other models, but inclusion of this integrin was considered beyond the scope of this study as VLA-4 has been shown not be involved in monocyte attachment under flow 36 , and is not specifically up-regulated in retinal venules in EAU 16 .
Our experiments show that while PSGL-1 has a partial role in regulating monocyte migration into the inflamed retina, CD62-L and CD44 were absolutely required for effective monocyte trafficking to the retina in EAU. The accumulation of monocytes in the spleens of CD62-L mAb treated EAU but not control mice is unexplained. Immuno-staining of lymph nodes and spleens from normal and EAU mice showed no obvious differences in expression of CD44 or CD62L (data not shown). This is perhaps not surprising as in this organ specific inflammatory model, the focus of inflammation is limited to the retina of the eye. The restriction of eGFP +ve cells to the subcapsular region of the lymph nodes in MEL-14 treated mice is consistent with a defect in the ability of these cells to traverse HEV, particularly during inflammation. In contrast, the spleen has no HEV so in MEL-14 treated animals monocytes were able traffic freely through this tissue.
MEL-14 mAb at high concentrations (100µg per mouse) has been reported to affect cell trafficking, particularly of lymphocytes 29 but a dose of 30µg per mouse per day appeared to have no significant effect on monocyte trafficking in our control mice. Sialomucin (CD43) as well as CD62-L is involved in monocyte migration into lymph nodes from the blood via high endothelial venules (HEV) 14 and our data would indicate that CD62-L is not necessary, or largely redundant in monocyte trafficking in the normal mouse, consistent with data from L-selectin-deficient mice 37 .
The inflammation specific nature of sequestering would imply that monocyte expressed CD62-L or its endothelial cell expressed ligands have undergone modification in response to the EAU 35 . Our previous observation that rolling is an acquired characteristic of adoptively transferred CD62-L + monocytes in mice with EAU, and that inflamed endothelium alone does not permit monocyte rolling 3 In conclusion, we demonstrate for the first time that the mechanisms controlling monocyte recirculation through peripheral and lymphoid tissues via the blood alters during inflammation, and we also show that the effect is systemic. Differential trafficking is known to be required for the selective recruitment of naïve or effector T cells either to sites of inflammation or to lymphoid tissues 37, 38 . Our data suggests that differential trafficking of monocytes also occurs during inflammation, and that regulation of ligand density or post-translational modification of CD44 and CD62-L may be involved. Thus post-translational modification of CD44 is required to maintain monocytes within the circulation during inflammation and mediate homing to the inflammatory site, and CD62-L may be less important during inflammation but necessary for recruitment to the lymph node. PSGL-1 was also shown to be involved in monocyte rolling and recruitment to an inflammatory site. The SLO data also supports our earlier hypothesis that monocytes must undergo maturation and differentiation in the circulation before they acquire the ability to roll on inflamed 
